Previous 10 | Next 10 |
2023-05-02 02:55:33 ET Summary My dividend income detracted 5.8% from January 2023 due to no longer owning any REITs. Dividend income grew 23.7% year over year, reflecting consistent and robust purchases over the previous year. I added four new positions this month, all of whi...
ALDEVRON ANNOUNCES EXPANSION OF mRNA PRODUCTION CAPABILITY PR Newswire Will offer mRNA cGMP Production from Master Cell Bank to Drug Product Made Possible with Precision Nanosystems and Cytiva FARGO, N.D. , May 1, 2023 /PRNewsw...
2023-04-27 18:03:18 ET Summary Revenue should benefit from price increases and good end-market demand. Margins should benefit from volume leverage, moderating inflation, and price increases. Valuation is at a discount compared to the peers and the recent stock correction repre...
2023-04-27 17:49:55 ET Summary GE Healthcare Technologies faced some pressure despite posting attractive financial results for the latest quarter. Overall, the company looks to be in solid shape and its future looks bright, especially with recent new wins under its belt. Add o...
2023-04-26 13:15:33 ET Wall Street continued to avoid pandemic plays as shares of the two leading COVID-19 vaccine makers in the U.S., Pfizer ( NYSE: PFE ) and BioNTech ( NASDAQ: BNTX ), reached new 52-week lows on Wednesday, albeit at below-average volumes. Pfizer ( ...
2023-04-26 07:07:17 ET COVID-leveraged healthcare firms continued to disappoint in the Q1 2023 earnings season as Thermo Fisher Scientific ( NYSE: TMO ) fell ~4% in the pre-market Wednesday after reporting a ~9% YoY decline in its quarterly topline driven by its underperformin...
2023-04-26 06:00:00 ET Summary Danaher just reported its 1Q23 earnings, which included somewhat weak guidance, causing the stock to sell off. While COVID benefits are unwinding rapidly, pressuring 1Q results and its outlook, the company remains upbeat about its core business, whic...
2023-04-25 12:53:00 ET Stocks got off to a tough start on Tuesday, as market participants looked closely at the latest slate of earnings results. Although key players in the technology industry will report earnings later this week, some other areas have failed to inspire confidence among th...
2023-04-25 11:45:23 ET Danaher Corporation (DHR) Q1 2023 Earnings Conference Call April 25, 2023 08:00 ET Company Participants John Bedford - Vice President, Investor Relations Rainer Blair - President and Chief Executive Officer Matt McGrew - Executive Vice Pres...
2023-04-25 07:07:18 ET Despite posting better-than-expected financials for Q1 2023, Danaher Corporation ( NYSE: DHR ) dropped ~5% pre-market Tuesday as the company's topline indicated a ~7% YoY contraction due to lower COVID-related sales. "Our team's focused execution in a ...
News, Short Squeeze, Breakout and More Instantly...
2024-07-26 10:45:04 ET Pacific Biosciences of California Inc (PACB) PACB is trading UP for the last 5 days, and it at trading at $2.10 with volume of 3,952,245 and a one day change of $0.19 (9.97%). Pacific Biosciences of California Inc has a 52-week low of 1.16 and a 52-week high o...
Beckman Coulter's DxI 9000 Immunoassay Analyzer Honored at Premier, Inc.'s Annual Supplier Innovation Celebration PR Newswire BREA, Calif. , July 25, 2024 /PRNewswire/ -- Beckman Coulter Diagnostics, a clinical diagnostics leader, today announced that the Dx...
2024-07-23 20:30:03 ET Goldman Sachs analyst issues NEUTRAL recommendation for DHR on July 23, 2024 06:19PM ET. The previous analyst recommendation was Neutral. DHR was trading at $264.18 at issue of the analyst recommendation. The overall analyst consensus : BUY. Cu...